SCHEMBL7089571

SCHEMBL7089571

c1cc(-c2ccsc2)c2cc[nH]c2c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 3/20 0.60
ASH1L Q9NR48 1/20 0.48
KDR P35968 1/20 0.47
PIK3CB P42338 2/20 0.46
IMPDH2 P12268 1/20 0.45
CSNK2B P67870 1/20 0.44
CSNK2A1 P68400 1/20 0.44
PIK3CG P48736 1/20 0.44
AHR P35869 1/20 0.43
ATR Q13535 1/20 0.42
PIP4K2A P48426 1/20 0.39
PIP4K2B P78356 1/20 0.39
PIP4K2C Q8TBX8 1/20 0.39
CHEK1 O14757 1/20 0.39
CYP2E1 P05181 1/20 0.38
CYP2A6 P11509 1/20 0.38
CYP2B6 P20813 1/20 0.38
RHEB Q15382 2/20 0.38
HPGDS O60760 1/20 0.38
CDK8 P49336 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10945814 0.79 PIK3CD (0.75) PIK3CDASH1LKDRPIK3CBIMPDH2
SCHEMBL26259994 0.79 CYP2A6 (0.52) PIK3CDKDRPIK3CBIMPDH2CYP2E1
SCHEMBL20561837 0.77 KDR (0.71) ASH1LKDRIMPDH2CDK8
SCHEMBL20540332 0.77 PIK3CD (0.64) PIK3CDASH1LPIK3CBCSNK2BCSNK2A1
SCHEMBL2193011 0.76 PIK3CD (0.70) PIK3CDASH1LKDRPIK3CBIMPDH2
SCHEMBL29712113 0.76 PIK3CD (0.70) PIK3CDASH1LKDRPIK3CBIMPDH2
SCHEMBL5831286 0.75 PIK3CD (1.00) PIK3CDASH1LKDRPIK3CBIMPDH2
SCHEMBL31675815 0.75 PIK3CD (1.00) PIK3CDASH1LKDRPIK3CBIMPDH2
SCHEMBL9212052 0.75 IMPDH2 (0.38) KDRIMPDH2CYP2E1CYP2A6CYP2B6
SCHEMBL27725234 0.73 PIK3CD (0.66) PIK3CDASH1LKDRPIK3CBIMPDH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030203959-A1 Novel modulators of potassium channels 4SC AG (DE) 2003-10-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030203959-A1 Novel modulators of potassium channels HCN3, KCNN3, KCNN1 PIK3CD 3331/4885ASH1L 3744/4885KDR 1266/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.